Page last updated: 2024-08-21

perflexane and Chronic Lung Injury

perflexane has been researched along with Chronic Lung Injury in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bleyl, JU; de Abreu, MG; Heintz, M; Heller, AR; Hübler, M; Koch, R; Koch, T; Schlemmer, M; Spieth, PM1
Bleyl, JU; Fehrenbach, A; Fehrenbach, H; Gama de Abreu, M; Heintz, M; Heller, AR; Hübler, M; Klenz, G; Koch, T; Spieth, PM1

Other Studies

2 other study(ies) available for perflexane and Chronic Lung Injury

ArticleYear
Effects of perfluorohexane vapor in the treatment of experimental lung injury.
    Pulmonary pharmacology & therapeutics, 2010, Volume: 23, Issue:5

    Topics: Animals; Calcimycin; Disease Models, Animal; Dose-Response Relationship, Drug; Epoprostenol; Female; Fluorocarbons; In Vitro Techniques; Ionophores; Leukotriene B4; Lung; Lung Injury; Organ Size; Positive-Pressure Respiration; Pulmonary Artery; Pulmonary Circulation; Pulmonary Edema; Rabbits; Thromboxane A2; Vascular Resistance; Volatilization

2010
Pretreatment with perfluorohexane vapor attenuates fMLP-induced lung injury in isolated perfused rabbit lungs.
    Experimental lung research, 2010, Volume: 36, Issue:6

    Topics: Animals; Anti-Inflammatory Agents; Blood Pressure; Cytoprotection; Disease Models, Animal; Dose-Response Relationship, Drug; Fluorocarbons; In Vitro Techniques; Inflammation Mediators; Inhalation; Leukocytes; Lung; Lung Injury; N-Formylmethionine Leucyl-Phenylalanine; Organ Size; Perfusion; Pulmonary Artery; Pulmonary Edema; Rabbits; Time Factors; Volatilization

2010